Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Stephen R. Broderick, MD, MPHS

Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.

Ventilator-associated pneumonia after cardiac surgery: A meta-analysis and systematic review Siyi He, MD, Bocheng Chen, MD, Wei Li, MD, Junyan Yan, MD,

Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass Minna Ilmakunnas, MD, Eero J. Pesonen,

Complete but not partial thymectomy in early infancy reduces T-cell–mediated immune response: Three-year tracing study after pediatric cardiac surgery

David W. Barbara, MD, William J. Mauermann, MD, James R

Francisco Igor B. Macedo, MD, Enisa M

Yuji Hiramatsu, MDa, Nicolas Gikakis, BSEa, Harry L

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Ventilator-associated pneumonia after cardiac surgery: A meta-analysis and systematic review Siyi He, MD, Bocheng Chen, MD, Wei Li, MD, Junyan Yan, MD,

Insulin resistance and inflammation are a cause of hyperglycemia after pediatric cardiopulmonary bypass surgery Alejandro A. Floh, MD, Cedric Manlhiot,

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

Effect of adding postoperative noninvasive ventilation to usual care to prevent pulmonary complications in patients undergoing coronary artery bypass.

Intrinsic cardiac stem cells are essential for regeneration

Extended pericardiotomy avoids cardiopulmonary bypass during bilateral sequential lung transplantation Takahiro Oto, MD, Marc Rabinov, FRACS, Franklin.

Sequela-free long-term survival of a 65-year-old woman after 8 hours and 40 minutes of cardiac arrest from deep accidental hypothermia Marie Meyer, MD,

The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin.

Neuromuscular electrical stimulation may attenuate muscle proteolysis after cardiovascular surgery: A preliminary study Kotaro Iwatsu, PhD, PT, Yuki.

Effect of preoperative inhaled budesonide on pulmonary injury after cardiopulmonary bypass: A randomized pilot study Wei Gao, MD, Na Li, MS, Zhe-hao.

The Journal of Thoracic and Cardiovascular Surgery

Systemic effects of carbon dioxide insufflation technique for de-airing in left-sided cardiac surgery Maya Landenhed, MD, Faleh Al-Rashidi, MD, PhD,

Multilevel data analysis: What? Why? How?

Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all David Faraoni, MD,

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Optimal dose of aprotinin for neuroprotection and renal function in a piglet survival model Yusuke Iwata, MD, Toru Okamura, MD, Nobuyuki Ishibashi, MD,

Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: A randomized controlled trial Marcos A. Pavione, MD, Fabio Carmona,

Timing of surgery for pulmonary embolism: An evolving paradigm

The lord of the rings Antonio Miceli, MD, PhD

Hypogammaglobulinemia after cardiopulmonary bypass in infants

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

The impact of smoking in primary spontaneous pneumothorax

Marta Kelava, MD, Michael Robich, MD, MSPH, Penny L

Rohit K. Singal, MD, MSc, FRCSC, Rakesh C. Arora, MD, PhD, FRCSC

Niv Ad, MD, Sari D. Holmes, PhD, Paul S. Massimiano, MD, Anthony J

Stephen R. Broderick, MD, MPHS

Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: Clinical and economic outcomes Walter.

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Which is better to preserve pulmonary function: Short-term or prolonged leukocyte depletion during cardiopulmonary bypass? Kaiyu Tao, MD, Qi An, MD,

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

David L. Joyce, MD The Journal of Thoracic and Cardiovascular Surgery

Niv Ad, MD, Lawrence M. Wei, MD

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Ventilatory dependency after cardiovascular surgery

Taking UP the chronic pulmonary obstructive disease gauntlet

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Aortic valve replacement with the minimal extracorporeal circulation (Jostra MECC System) versus standard cardiopulmonary bypass: A randomized prospective.

The ascent of POEM: Double-tunnel per oral endoscopic re-myotomy

Shunt right or left? Decision 2016

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

The continuing challenge of congenital heart disease in China

External tracheal stenting for pediatric airway obstruction: A word of caution Roosevelt Bryant, MD The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Apples remain apples NO matter what

Preoperative PFTs: The answer is blowing in the wind

Sunjay Kaushal, MD, PhD, Brody Wehman, MD

Unexpected donor pulmonary embolism affects early outcomes after lung transplantation: A major mechanism of primary graft failure? Takahiro Oto, MD,

Y.John Gu, MD, PhD, Piet W. Boonstra, MD, PhD, Willem van Oeveren, PhD

Definitions of primary graft dysfunction after lung transplantation: Differences between bilateral and single lung transplantation Takahiro Oto, MD,

Edward Y. Chan, MD, Michael J. Reardon, MD

Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa.

Akiko Tanaka, MD, PhD, Takeyoshi Ota, MD, PhD

Zipping up after a median sternotomy: Are we at the end of the wire?

Deciding how much to pay for effective care

Presentation transcript:

Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary disease Nicolas de Prost, MD, PhD, Claudine El-Karak, MD, Maria Avila, MD, Fumito Ichinose, MD, PhD, Marcos F. Vidal Melo, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 141, Issue 6, Pages 1496-1502.e3 (June 2011) DOI: 10.1016/j.jtcvs.2011.01.035 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Ratio of arterial Po2 (Pao2) to inspired oxygen fraction (Fio2; A) and airway resistances (Raw; B) of patients with chronic obstructive pulmonary disease (COPD, filled circles, n = 9) and without chronic obstructive pulmonary disease (non-COPD, open circles, n = 10) at 5 major interventional phases: before sternotomy (Baseline), before and after cardiopulmonary bypass (CPB), after chest closure (chest closed), and 2 hours after intensive care unit admission (ICU). Horizontal bars represent median values. Single asterisk indicates P < .05; double asterisk indicates P < .01; triple asterisk indicates P < .001. P values are derived from 2-way analysis of variance with repeated measurements, with Bonferroni adjustments for multiple comparisons. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1496-1502.e3DOI: (10.1016/j.jtcvs.2011.01.035) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Plasma (A) and urinary (B) cysteinyl leukotriene concentrations in patients with chronic obstructive pulmonary disease (COPD, filled circles, n = 9 for plasma and n = 8 for urine samples) and without chronic obstructive pulmonary disease (non-COPD, open circles, n = 10) at 4 major interventional phases: before sternotomy (Baseline), at the end of cardiopulmonary bypass with continued extracorporeal circulation (End CPB), after cardiopulmonary bypass but before chest closure (After CPB), and 2 hours after intensive care unit admission (ICU). Horizontal bars represent median values. Single asterisk indicates P < .05; double asterisk indicates P < .01; triple asterisk indicates P < .001. P values are derived from 2-way analysis of variance with repeated measurements, with Bonferroni adjustments for multiple comparisons. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1496-1502.e3DOI: (10.1016/j.jtcvs.2011.01.035) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

White blood cell (A) and platelet (B) counts in patients with chronic obstructive pulmonary disease (COPD, filled circles, n = 9) and without chronic obstructive pulmonary disease (non-COPD, open circles, n = 10) at baseline before sternotomy (BL), after chest closure (CC), and 2 hours after intensive care unit admission (ICU). Horizontal bars represent median values. Double asterisk indicates P < .01; triple asterisk indicates P < .001. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1496-1502.e3DOI: (10.1016/j.jtcvs.2011.01.035) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Compliance of the respiratory system (Crs) in patients with chronic obstructive pulmonary disease (COPD, filled circles, n = 9) and without chronic obstructive pulmonary disease (non-COPD, open circles, n = 10) at 5 major interventional phases: before sternotomy (Baseline), before and after cardiopulmonary bypass (CPB), after chest closure (chest closed), and 2 hours after intensive care unit admission (ICU). Horizontal bars represent median values. Double asterisk indicates P < .01; triple asterisk indicates P < .001. P values are derived from 2-way analysis of variance with repeated measurements, with Bonferroni adjustments for multiple comparisons. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1496-1502.e3DOI: (10.1016/j.jtcvs.2011.01.035) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Plasma (A) and urinary (B) leukotriene B4 concentrations of patients with chronic obstructive pulmonary disease (COPD, filled circles, n = 9 for plasma and n = 8 for urine samples) and without chronic obstructive pulmonary disease (non-COPD, open circles, n = 10) at 4 major interventional phases: before sternotomy (Baseline), at the end of cardiopulmonary bypass with continued extracorporeal circulation (End CPB), after cardiopulmonary bypass but before chest closure (After CPB), and 2 hours after intensive care unit admission (ICU). Horizontal bars represent median values. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1496-1502.e3DOI: (10.1016/j.jtcvs.2011.01.035) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Cysteinyl leukotrienes (A) and leukotriene B4 (B) tracheal aspirate concentrations in 8 patients with COPD before sternotomy (Baseline) and after cardiopulmonary bypass (CPB). Horizontal bars represent median values. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1496-1502.e3DOI: (10.1016/j.jtcvs.2011.01.035) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions